By Kelly Cloonan Pfizer closed its acquisition of weight-loss drug startup Metsera in a deal that could be valued at more than $10 billion. Under the deal, Pfizer paid $65.60 a share in cash...
Pfizer Completes Acquisition of Metsera
By Kelly Cloonan Pfizer closed its acquisition of weight-loss drug startup Metsera in a deal that could be valued at more than $10 billion. Under the deal, Pfizer paid $65.60 a share in cash...